Observational studyUnited European gastroenterology journal2024

Initiation of vedolizumab did not provoke new-onset spondylarthritis in patients with inflammatory bowel disease: A prospective 24-week study with imaging assessments.

Sherry Rohekar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.